Outcomes of Non-Severe Relapses in ANCA-Associated Vasculitis Treated with Glucocorticoids

OBJECTIVE: Non-severe relapses are more common than severe relapses in ANCA-associated vasculitis (AAV), but their clinical course and treatment outcomes remain largely unexamined. We analyzed the outcomes of non-severe relapses in the Rituximab in AAV (RAVE) trial that were treated according to a p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arthritis Rheumatol
Auteurs principaux: Miloslavsky, EM, Specks, U, Merkel, PA, Seo, P, Spiera, R, Langford, CA, Hoffman, GS, Kallenberg, CGM, St. Clair, EW, Tchao, NK, Ding, L, Ikle, D, Villareal, M, Lim, N, Brunetta, P, Fervenza, FC, Monach, PA, Stone, JH
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956529/
https://ncbi.nlm.nih.gov/pubmed/25776953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39104
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires